Read More 1 minute read Analyst Ratings Downgrades News Price Target Baird Downgrades Franklin Electric to Neutral, Announces $75 Price Target By Benzinga Newsdesk July 14, 7:17 AM Baird analyst Michael Halloran downgrades Franklin Electric (NASDAQ:FELE) from Outperform to Neutral and announces $75 price target. FELE
Read More 1 minute read Analyst Ratings Downgrades News Price Target Baird Downgrades Graco to Neutral, Announces $61 Price Target By Benzinga Newsdesk July 14, 7:15 AM Baird analyst Michael Halloran downgrades Graco (NYSE:GGG) from Outperform to Neutral and announces $61 price target. GGG
Read More 1 minute read Analyst Ratings Downgrades News Price Target SVB Leerink Downgrades ContraFect to Market Perform, Lowers Price Target to $1 By Benzinga Newsdesk July 14, 7:09 AM SVB Leerink analyst Roanna Ruiz downgrades ContraFect (NASDAQ:CFRX) from Outperform to Market Perform and lowers the price target from $9 to $1. CFRX
Read More 1 minute read Analyst Ratings Downgrades News Price Target Wells Fargo Downgrades Fidelity National Info to Equal-Weight, Lowers Price Target to $101 By Benzinga Newsdesk July 14, 6:53 AM Wells Fargo analyst Jeff Cantwell downgrades Fidelity National Info (NYSE:FIS) from Overweight to Equal-Weight and lowers the price target from $132 to $101. FIS
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Nuvei to Neutral, Lowers Price Target to $40 By Benzinga Newsdesk July 14, 6:33 AM Goldman Sachs analyst Will Nance downgrades Nuvei (NASDAQ:NVEI) from Buy to Neutral and lowers the price target from $72 to $40. NVEI
Read More 1 minute read Analyst Ratings Downgrades News JMP Securities Downgrades Squarespace to Market Perform By Benzinga Newsdesk July 14, 6:29 AM JMP Securities analyst Andrew Boone downgrades Squarespace (NYSE:SQSP) from Market Outperform to Market Perform. SQSP
Read More 1 minute read Analyst Ratings Downgrades News Price Target Morgan Stanley Downgrades Outset Medical to Equal-Weight, Lowers Price Target to $20 By Benzinga Newsdesk July 14, 6:27 AM Morgan Stanley analyst Drew Ranieri downgrades Outset Medical (NASDAQ:OM) from Overweight to Equal-Weight and lowers the price target from $48 to $20. OM
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Dollar Gen to Neutral, Announces $258 Price Target By Benzinga Newsdesk July 14, 6:25 AM Citigroup analyst Paul Lejuez downgrades Dollar Gen (NYSE:DG) from Buy to Neutral and announces $258 price target. DG
Read More 1 minute read Analyst Ratings Downgrades News Price Target Wells Fargo Downgrades Fiserv to Equal-Weight, Announces $97 Price Target By Benzinga Newsdesk July 14, 6:22 AM Wells Fargo analyst Jeff Cantwell downgrades Fiserv (NASDAQ:FISV) from Overweight to Equal-Weight and announces $97 price target. FISV
Read More 1 minute read Analyst Ratings Downgrades News Price Target JP Morgan Downgrades Cisco Systems to Neutral, Lowers Price Target to $51 By Benzinga Newsdesk July 14, 5:06 AM JP Morgan analyst Samik Chatterjee downgrades Cisco Systems (NASDAQ:CSCO) from Overweight to Neutral and lowers the price target from $62 to $51. CSCO